Fig. 3.
Comparison of whole-brain global graph metrics between progressive supranuclear palsy patients and healthy controls.
Plots illustrate the distribution of the nodal degree, clustering coefficient, path length, small worldness and modularity in the whole-brain network between groups. Significance of intergroup analyses (p < 0.05, FDR corrected) are shown. HC: healthy controls; PSP: progressive supranuclear palsy group.